Cure4Glioma Network

Cures4Glioma (C4G) is a network designed to unite glioma researchers with the goal of accelerating discovery and making meaningful steps forward in the glioma field. Members meet monthly and meetings are open to all. Please reach out to Kimberly Scott, Coordinator for details. 

Short Term Goals:

  • establish a web portal listing the credentials and contacts for glioma researchers interested in collaboration and working toward shared resources - DONE!
  • bring together resources that can be shared among the glioma community with proper approvals (eg. tissues, databases, cell lines, animal models) 
  • provide a hub for listing opportunities and upcoming events in the glioma field - DONE!
  • support training and research advancement through a blog site and social media avenues to rapidly share ideas and ask questions.

Long Term Goals:

  • provide a pipeline of shared resources, technology and expertise to accelerate promising avenues of glioma research - currently hosting monthly meetings
  • increase funding opportunitites and partnerships for glioma researchers
  • to provide trainee support and opportunitites for the next generation of glioma researchers - opportunity to present at monthly meetings

The Following Institutions are represented by our members 


Centre for Translational Cancer Research
German Cancer Research Centre
Hamilton Health Sciences 
Henry Ford Cancer Institute
Henry Ford Health System
Hospital for Sick Children
Hospital for Sick Kids Research Institute
Lawson Health Research Institute
London Health Sciences Centre
London Regional Cancer Program
McMaster Children's Hospital
Michigan State University
Ontario Institute for Cancer Research



Lisa Porter, PhD.

Professor, Department of Biomedical Sciences, University of Windsor. Executive Director, WE-SPARK Health Institute.

Research Interests / Specializations: Molecular/cell biology as it pertains to cancer biology and links to normal development. Focus on cell cycle and cell growth regulation in breast, brain, liver, prostate cancer. Uses mouse and zebrafish models as well as cell lines and patient-derived samples and clinical data.


Robarts Research Institute
Schulich School of Medicine & Dentistry
Schulich School of Medicine & Dentistry - Windsor
Sunnybrook Health Sciences Centre
University of Alberta
University Hospital Heidelberg
University of Toronto 
University of Windsor
WE-Spark Health Institute
Western University
Windsor Cancer Research Program
Windsor Regional Hospital



John Ronald, PhD.

Assistant Professor, Department of Medical Biophysics. Scientist, Robarts Research Institute. Associate Scientist, Lawson Health Research Institute.

Research Interests / Specializations: Research focusees on pioneering novel molecular and cellular imaging technologies. Specific interest on improving early cancer detection, improved monitoring state-of-the-art gene-based and cell-based therapies for cancer and other disease.